Profil
Michael A.
Byrne is Chief Financial Officer and Corporate Secretary of Viventia Biotech, Inc. Prior to joining Viventia, he was Chief Financial Officer of Hyal Pharmaceuticals, Inc. Mr. Byrne has over 20 years of executive experience in the biotech and pharmaceutical sector.
Postes actifs de Michael A. Byrne
Sociétés | Poste | Début |
---|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Directeur Financier/CFO | 01/01/2000 |
Anciens postes connus de Michael A. Byrne
Sociétés | Poste | Fin |
---|---|---|
Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Hyal Pharmaceutical Corp. | Health Technology |